Nidan Labs & Healthcare
add_icon

Nidan Labs & Healthcare

15.50
-1.10
(-6.63%)
Market Cap
21.50 Cr
PE Ratio
10.92
Volume
9,000.00
Day High - Low
15.70 - 15.50
52W High-Low
24.90 - 15.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
21.50 Cr
EPS
1.42
PE Ratio
10.92
PB Ratio
0.32
Book Value
49.05
EBITDA
7.30
Dividend Yield
0.00 %
Return on Equity
2.90
Debt to Equity
0.18
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,363.80
#1 22,850.60
42.87
#1 2,554.80
11.28
#1 492
-6.83
41.09
946.70
9,725.00
60.91
699.70
23.06
144
22.38
39.77
1,783.00
9,239.90
54.56
1,346.30
10.64
146
33.65
33.66
375.15
5,971.00
43.99
702.20
20.80
91
47.37
34.50
561.70
5,636.10
79.09
769.90
33.97
67
60.20
52.22
588.10
1,907.70
23.73
742.70
16.70
78
-21.13
24.29
260.55
1,357.00
40.93
255.90
15.11
31
20.00
35.07
604.35
1,181.10
18.97
147.80
#1 134.60
19
#1 520.00
43.73
1,206.70
1,035.70
#1 17.81
111.60
28.72
48
65.93
28.04
271.00
862.10
29.73
1,170.80
-18.47
-134
101.06
36.22
Growth Rate
Revenue Growth
-0.37 %
Net Income Growth
-162.50 %
Cash Flow Change
-58.70 %
ROE
-159.43 %
ROCE
-2,692.31 %
EBITDA Margin (Avg.)
-20.01 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
21
22
21
30
28
27
27
24
Expenses
13
15
12
20
18
18
20
15
EBITDA
8
8
10
10
10
9
7
9
Operating Profit %
38 %
34 %
44 %
32 %
28 %
27 %
21 %
19 %
Depreciation
3
3
3
3
3
3
2
3
Interest
5
4
4
3
2
2
2
3
Profit Before Tax
0
1
3
5
5
-2
3
4
Tax
0
0
1
2
1
1
1
1
Net Profit
0
1
2
3
4
-3
2
3
EPS in ₹
0.23
0.72
2.33
2.32
2.55
-2.33
1.42
2.90

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
43
45
54
89
84
83
83
Fixed Assets
23
20
20
21
21
18
16
Current Assets
19
24
23
25
21
30
11
Capital Work in Progress
0
0
0
4
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
20
25
34
64
63
65
67
Total Equity & Liabilities
43
45
54
89
84
83
83
Current Liabilities
1
-0
26
13
10
11
10
Non Current Liabilities
32
34
14
10
5
5
5
Total Equity
10
11
13
66
69
66
68
Reserve & Surplus
0
1
3
52
56
52
54
Share Capital
10
10
10
14
14
14
14

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
4
3
-0
1
0
-6
-1
Investing Activities
1
0
-3
-36
-0
-11
-0
Operating Activities
9
5
4
8
11
6
2
Financing Activities
-6
-2
-1
29
-10
-1
-3

Share Holding

% Holding
Oct 2021
Nov 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Dec 2025
Promoter
99.99 %
71.22 %
71.22 %
71.22 %
71.22 %
62.79 %
57.04 %
57.04 %
57.04 %
57.04 %
57.04 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
20.86 %
26.60 %
25.63 %
26.62 %
33.22 %
39.33 %
39.60 %
39.78 %
40.01 %
40.05 %
Others
0.01 %
7.92 %
2.18 %
3.15 %
2.16 %
3.99 %
3.64 %
3.36 %
3.18 %
2.95 %
2.92 %
No of Share Holders
15
2,940
2,791
2,516
2,440
2,777
2,864
2,790
2,581
2,489
2,437

Technical Indicators

RSI(14)
Neutral
49.02
ATR(14)
Less Volatile
0.71
STOCH(9,6)
Neutral
25.85
STOCH RSI(14)
Neutral
30.09
MACD(12,26)
Bullish
0.01
ADX(14)
Weak Trend
19.70
UO(9)
Bearish
44.33
ROC(12)
Downtrend And Accelerating
-2.35
WillR(14)
Neutral
-62.26